Overview

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
To compare the rate of absorption and oral bioavailability of a test formulation of Sertraline 100 mg tablets manufactured by Purepac Pharmaceutical Company to an equivalent oral dose of the commercially available reference product, Zoloft® manufactured by Pfizer Inc. administrated to healthy subjects after a 10-ghour overnight fast
Phase:
Phase 1
Details
Lead Sponsor:
Actavis Inc.
Treatments:
Sertraline